FIELD: medicine.
SUBSTANCE: invention refers to medicine and veterinary science and concerns applications of 4-trifluoromethylbenzyl ester (S)-3-[3-(1-carboxy-1-methylethoxy)phenyl]piperidine -1-carboxylic acid in preparation of a medical product for palliative, preventive or medicinal therapy of negative energy balance in ruminants, where said disease is chosen from fatty liver syndrome, allotopia, dysimmunity, immunosuppression, toxification, primary and secondary ketosis, cow mortality syndrome, digestive disorder, appetite loss, retained placenta, slipped abomasum, mastitis, (endo-)-metritis, barrenesses, low fertility and claudification.
EFFECT: invention ensures high clinical effectiveness.
6 cl, 4 dwg, 8 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CARBOXYLIC ACID DERIVATIVES CONTAINING 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING | 2011 |
|
RU2564018C2 |
| NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR TREATMENT OF DISEASES | 2008 |
|
RU2524949C2 |
| 2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
| SUBSTITUTED DERIVATIVES OF IMIDAZOLIDINE, METHOD FOR PREPARING AND PHARMACEUTICAL PREPARATION | 1998 |
|
RU2239641C2 |
| NEW COMPOUNDS | 2001 |
|
RU2261245C2 |
| SUBSTITUTED DERIVATIVES OF 3-THIAZOLAMINEPROPIONIC ACID AND THEIR USE AS PHARMACEUTICALS | 2012 |
|
RU2617843C2 |
| TETRAHYDROBENZIMIDAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684637C1 |
| PHENYL DERIVATIVES AS PPAR AGONISTS | 2004 |
|
RU2374230C2 |
| PURINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684644C1 |
| HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING | 2011 |
|
RU2559896C2 |
